Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Liming Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0914-6113; OpenAlex author ID A5101910726. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Establishment of a nomogram model for predicting distant metastasis in pancreatic ductal adenocarcinoma: a comparative analysis of different lymph node staging… Last author DOI 10.1038/s41598-024-69126-8↗
  2. [Corrigendum] Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Co-author DOI 10.3892/ijmm.2023.5303↗
  3. Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Co-author DOI 10.3892/ijmm.2012.884↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuechuan Liu · 1 shared paper, 2024 · strength 0.31
  2. Du Jian · 1 shared paper, 2023 · strength 0.20
  3. Zhongyu Wang · 1 shared paper, 2023 · strength 0.20
  4. Bo Tang · 1 shared paper, 2012 · strength 0.03
  5. Zhongyu Wang · 1 shared paper, 2012 · strength 0.03
  6. Jian Du · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.